Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Agios Pharmaceuticals
AGIO
$1.97B
| $10.2M | ﹤0.01% |
456,394
+4,699
| +1% | +$105K |
|
|
UDMY
1977
DELISTED
Udemy
UDMY
| $10.2M | ﹤0.01% |
689,768
+23,652
| +4% | +$295K |
|
1978
UFP Technologies
UFPT
$2.16B
| $10.2M | ﹤0.01% |
59,004
+1,934
| +3% | +$313K |
|
1979
Cerence
CRNC
$355M
| $10.1M | ﹤0.01% |
515,301
+1,054
| +0.2% | +$18.3K |
|
1980
Vanguard High Dividend Yield ETF
VYM
$81.1B
| $10.1M | ﹤0.01% |
94,579
+5,646
| +6% | +$593K |
|
1981
VictoryShares US Small Mid Cap Value Momentum ETF
USVM
$1.74B
| $10.1M | ﹤0.01% |
137,496
-4,246
| -3% | -$282K |
|
1982
State Street SPDR Portfolio TIPS ETF
SPIP
$1.01B
| $10.1M | ﹤0.01% |
394,874
-71,082
| -15% | -$1.78M |
|
|
SHOE
1983
Shoe Station Group
SHOE
$351M
| $10.1M | ﹤0.01% |
333,411
+20,941
| +7% | +$527K |
|
1984
Krispy Kreme
DNUT
$540M
| $10M | ﹤0.01% |
665,957
+7,745
| +1% | +$102K |
|
1985
Heartland Express
HTLD
$919M
| $10M | ﹤0.01% |
704,437
+31,045
| +5% | +$425K |
|
1986
Center Bancorp
CNOB
$1.59B
| $10M | ﹤0.01% |
438,198
+41,010
| +10% | +$790K |
|
|
INN
1987
Summit Hotel Properties
INN
$614M
| $10M | ﹤0.01% |
1,491,396
+99,732
| +7% | +$614K |
|
|
EHAB
1988
DELISTED
Enhabit
EHAB
| $10M | ﹤0.01% |
966,515
+193,675
| +25% | +$1.83M |
|
1989
Globant
GLOB
$1.66B
| $9.99M | ﹤0.01% |
41,970
+2,470
| +6% | +$504K |
|
1990
MiMedx Group
MDXG
$690M
| $9.95M | ﹤0.01% |
1,134,213
+57,704
| +5% | +$423K |
|
|
AKRO
1991
DELISTED
Akero Therapeutics
AKRO
| $9.94M | ﹤0.01% |
425,545
+6,115
| +1% | +$121K |
|
1992
AstraZeneca
AZN
$253B
| $9.92M | ﹤0.01% |
73,626
+12,117
| +20% | +$1.58M |
|
|
THR
1993
DELISTED
Thermon Group Holdings
THR
| $9.88M | ﹤0.01% |
303,493
+44,321
| +17% | +$1.32M |
|
|
INFA
1994
DELISTED
Informatica
INFA
| $9.88M | ﹤0.01% |
348,121
+11,476
| +3% | +$276K |
|
1995
Hayward Holdings
HAYW
$2.74B
| $9.88M | ﹤0.01% |
726,668
+15,266
| +2% | +$188K |
|
1996
Tompkins Financial
TMP
$1.4B
| $9.86M | ﹤0.01% |
163,688
+9,442
| +6% | +$513K |
|
1997
Barrett Business Services
BBSI
$831M
| $9.84M | ﹤0.01% |
339,780
+5,008
| +1% | +$129K |
|
1998
Vanguard Intermediate-Term Bond ETF
BIV
$28.4B
| $9.83M | ﹤0.01% |
128,697
-19,657
| -13% | -$1.44M |
|
1999
Ducommun
DCO
$2.59B
| $9.81M | ﹤0.01% |
188,363
+10,090
| +6% | +$493K |
|
|
NVO
2000
Novo Nordisk
NVO
$184B
| $9.78M | ﹤0.01% |
94,544
+26,067
| +38% | +$2.58M |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.